Ankylosing Spondylitis Drug includes Nonsteroidal anti-inflammatory drugs (NSAIDs) - such as naproxen (Naprosyn) and indomethacin (Indocin, Tivorbex) - are the medications doctors most commonly use to treat ankylosing spondylitis. They can relieve your inflammation, pain and stiffness.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Ankylosing Spondylitis Drug industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Cimzia
Enbrel
Humira
Remicade
Simponi
Others
Market Segment by Product Application
Hospitals
Clinics
Finally, the report provides detailed profile and data information analysis of leading company.
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai
Pfizer
Johnson & Johnson
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Ankylosing Spondylitis Drug consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Ankylosing Spondylitis Drug market by identifying its various subsegments.
3.Focuses on the key global Ankylosing Spondylitis Drug manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Ankylosing Spondylitis Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Ankylosing Spondylitis Drug submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Ankylosing Spondylitis Drug Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Ankylosing Spondylitis Drug Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Ankylosing Spondylitis Drug Segment by Type
2.1.1 Cimzia
2.1.2 Enbrel
2.1.3 Humira
2.1.4 Remicade
2.1.5 Simponi
2.1.6 Others
2.2 Market Analysis by Application
2.2.1 Hospitals
2.2.2 Clinics
2.3 Global Ankylosing Spondylitis Drug Market Comparison by Regions (2017-2027)
2.3.1 Global Ankylosing Spondylitis Drug Market Size (2017-2027)
2.3.2 North America Ankylosing Spondylitis Drug Status and Prospect (2017-2027)
2.3.3 Europe Ankylosing Spondylitis Drug Status and Prospect (2017-2027)
2.3.4 China Ankylosing Spondylitis Drug Status and Prospect (2017-2027)
2.3.5 Japan Ankylosing Spondylitis Drug Status and Prospect (2017-2027)
2.3.6 Southeast Asia Ankylosing Spondylitis Drug Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Ankylosing Spondylitis Drug Industry Impact
2.5.1 Ankylosing Spondylitis Drug Business Impact Assessment - Covid-19
2.5.2 Market Trends and Ankylosing Spondylitis Drug Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Ankylosing Spondylitis Drug Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Ankylosing Spondylitis Drug Manufacturer Market Share
3.5 Top 10 Ankylosing Spondylitis Drug Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Ankylosing Spondylitis Drug Market
3.7 Key Manufacturers Ankylosing Spondylitis Drug Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Ankylosing Spondylitis Drug Industry Key Manufacturers
4.1 Amgen
4.1.1 Compan Detail
4.1.2 Amgen Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.1.3 Amgen 132 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Amgen News
4.2 Wyeth
4.2.1 Compan Detail
4.2.2 Wyeth Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.2.3 Wyeth Ankylosing Spondylitis Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Amgen News
4.3 Takeda
4.3.1 Compan Detail
4.3.2 Takeda Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.3.3 Takeda Ankylosing Spondylitis Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Takeda News
4.4 Centocor
4.4.1 Compan Detail
4.4.2 Centocor Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.4.3 Centocor Ankylosing Spondylitis Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Centocor News
4.5 Schering-Plough
4.5.1 Compan Detail
4.5.2 Centocor Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.5.3 Schering-Plough Ankylosing Spondylitis Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Schering-Plough News
4.6 Mitsubishi Tanabe
4.6.1 Compan Detail
4.6.2 Mitsubishi Tanabe Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Mitsubishi Tanabe News
4.7 Abbott
4.7.1 Compan Detail
4.7.2 Abbott Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.7.3 Abbott Ankylosing Spondylitis Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Eisai
4.8.1 Compan Detail
4.8.2 Eisai Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.8.3 Eisai Ankylosing Spondylitis Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Eisai News
4.9 Pfizer
4.9.1 Compan Detail
4.9.2 Pfizer Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.9.3 Pfizer Ankylosing Spondylitis Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Pfizer News
4.10 Johnson & Johnson
4.10.1 Compan Detail
4.10.2 Johnson & Johnson Ankylosing Spondylitis Drug Product Introduction, Application and Specification
4.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Johnson & Johnson News
5 Global Ankylosing Spondylitis Drug Market Segment by Big Type
5.1 Global Ankylosing Spondylitis Drug Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Ankylosing Spondylitis Drug Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Ankylosing Spondylitis Drug Revenue and Market Share by Big Type (2017-2022)
5.2 Cimzia Sales Growth Rate and Price
5.2.1 Global Cimzia Sales Growth Rate (2017-2022)
5.2.2 Global Cimzia Price (2017-2022)
5.3 Enbrel Sales Growth Rate and Price
5.3.1 Global Enbrel Sales Growth Rate (2017-2022)
5.3.2 Global Enbrel Price (2017-2022)
5.4 Humira Sales Growth Rate and Price
5.4.1 Global Humira Sales Growth Rate (2017-2022)
5.4.2 Global Humira Price (2017-2022)
5.5 Remicade Sales Growth Rate and Price
5.5.1 Global Remicade Sales Growth Rate (2017-2022)
5.5.2 Global Remicade Price (2017-2022)
5.6 Simponi Sales Growth Rate and Price
5.6.1 Global Simponi Sales Growth Rate (2017-2022)
5.6.2 Global Simponi Price (2017-2022)
5.7 Others Sales Growth Rate and Price
5.7.1 Global Others Sales Growth Rate (2017-2022)
5.7.2 Global Others Price (2017-2022)
6 Global Ankylosing Spondylitis Drug Market Segment by Big Application
6.1 Global Ankylosing Spondylitis Drug Sales Market Share by Big Application (2017-2022)
6.2 Hospitals Sales Growth Rate (2017-2022)
6.3 Clinics Sales Growth Rate (2017-2022)
7 Global Ankylosing Spondylitis Drug Forecast
7.1 Global Ankylosing Spondylitis Drug Revenue, Sales and Growth Rate (2022-2027)
7.2 Ankylosing Spondylitis Drug Market Forecast by Regions (2022-2027)
7.2.1 North America Ankylosing Spondylitis Drug Market Forecast (2022-2027)
7.2.2 Europe Ankylosing Spondylitis Drug Market Forecast (2022-2027)
7.2.3 China Ankylosing Spondylitis Drug Market Forecast (2022-2027)
7.2.4 Japan Ankylosing Spondylitis Drug Market Forecast (2022-2027)
7.2.5 Southeast Asia Ankylosing Spondylitis Drug Market Forecast (2022-2027)
7.2.6 Other Regions Ankylosing Spondylitis Drug Market Forecast (2022-2027)
7.3 Ankylosing Spondylitis Drug Market Forecast by Type (2022-2027)
7.3.1 Global Ankylosing Spondylitis Drug Sales Forecast by Type (2022-2027)
7.3.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Type (2022-2027)
7.4 Ankylosing Spondylitis Drug Market Forecast by Application (2022-2027)
7.4.1 Global Ankylosing Spondylitis Drug Sales Forecast by Application (2022-2027)
7.4.2 Global Ankylosing Spondylitis Drug Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Ankylosing Spondylitis Drug Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Ankylosing Spondylitis Drug Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Ankylosing Spondylitis Drug
Figure Market Concentration Ratio and Market Maturity Analysis of Ankylosing Spondylitis Drug
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Ankylosing Spondylitis Drug Market Size by Big Type
Figure Global Market Share of Ankylosing Spondylitis Drug by Big Type in 2021
Figure Cimzia Picture (2017-2022)
Figure Enbrel Picture (2017-2022)
Figure Humira Picture (2017-2022)
Figure Remicade Picture (2017-2022)
Figure Simponi Picture (2017-2022)
Global Ankylosing Spondylitis Drug Market Size by Big Application
Table Global Ankylosing Spondylitis Drug Market Size by Application
Figure Global Ankylosing Spondylitis Drug Market Share by Big Application in 2021
Figure Hospitals Picture
Figure Clinics Picture
Table Global Ankylosing Spondylitis Drug Comparison by Regions (M USD) (2017-2027)
Figure Global Ankylosing Spondylitis Drug Market Size (Million US$) (2017-2027)
Figure North America Ankylosing Spondylitis Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Ankylosing Spondylitis Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure China Ankylosing Spondylitis Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Ankylosing Spondylitis Drug Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Ankylosing Spondylitis Drug Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Ankylosing Spondylitis Drug Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Ankylosing Spondylitis Drug Sales by Manufacturer (2017-2022)
Figure Global Ankylosing Spondylitis Drug Sales Market Share by Manufacturer in 2021
Table Global Ankylosing Spondylitis Drug Revenue by Manufacturer (2017-2022)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share by Manufacturer in 2021
Table Global Ankylosing Spondylitis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Ankylosing Spondylitis Drug Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Ankylosing Spondylitis Drug Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Ankylosing Spondylitis Drug Market
Table Key Manufacturers Ankylosing Spondylitis Drug Product Type
Table Mergers & Acquisitions Planning
Table Amgen Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Amgen
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Wyeth Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Wyeth
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Wyeth Recent Development
Table Takeda Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Takeda
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Takeda Main Business
Table Takeda Recent Development
Table Centocor Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Centocor
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Centocor Main Business
Table Centocor Recent Development
Table Centocor Main Business
Table Centocor Recent Development
Table Schering-Plough Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Schering-Plough
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Schering-Plough Main Business
Table Schering-Plough Recent Development
Table Mitsubishi Tanabe Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Mitsubishi Tanabe
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mitsubishi Tanabe Main Business
Table Mitsubishi Tanabe Recent Development
Table Abbott Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Abbott
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Abbott Main Business
Table Abbott Recent Development
Table Eisai Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Eisai
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eisai Main Business
Table Eisai Recent Development
Table Pfizer Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Pfizer
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Pfizer Main Business
Table Pfizer Recent Development
Table Johnson & Johnson Company Profile
Table Ankylosing Spondylitis Drug Product Introduction, Application and Specification of Johnson & Johnson
Table Ankylosing Spondylitis Drug Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Johnson & Johnson Main Business
Table Johnson & Johnson Recent Development
Figure Global Ankylosing Spondylitis Drug Sales and Growth Rate (2017-2022)
Figure Global Ankylosing Spondylitis Drug Revenue and Growth Rate (2017-2022)
Table Global Ankylosing Spondylitis Drug Sales by Regions (2017-2022)
Figure Global Ankylosing Spondylitis Drug Sales Market Share by Regions in 2021
Table Global Ankylosing Spondylitis Drug Revenue by Regions (2017-2022)
Figure Global Ankylosing Spondylitis Drug Revenue Market Share by Regions in 2021
Figure North America Ankylosing Spondylitis Drug Sales and Growth Rate (2017-2022)
Figure Europe Ankylosing Spondylitis Drug Sales and Growth Rate (2017-2022)
Figure China Ankylosing Spondylitis Drug Sales and Growth Rate (2017-2022)
Figure Japan Ankylosing Spondylitis Drug Sales and Growth Rate (2017-2022)
Figure Southeast Asia Ankylosing Spondylitis Drug Sales and Growth Rate (2017-2022)
Figure Other Regions Ankylosing Spondylitis Drug Sales and Growth Rate (2017-2022)
Table Global Ankylosing Spondylitis Drug Sales by Big Type (2017-2022)
Table Global Ankylosing Spondylitis Drug Sales Market Share by Big Type (2017-2022)
Figure Global Ankylosing Spondylitis Drug Sales Market Share by Big Type in 2019
Table Global Ankylosing Spondylitis Drug Revenue by Big Type (2017-2022)
Table Global Ankylosing Spondylitis Drug Revenue Market Share by Big Type (2017-2022)
Table Global Ankylosing Spondylitis Drug Revenue Market Share by Big Type in 2019
Figure Global Cimzia Sales Growth Rate (2017-2022)
Figure Global Cimzia Price (2017-2022)
Figure Global Enbrel Sales Growth Rate (2017-2022)
Figure Global Enbrel Price (2017-2022)
Figure Global Humira Sales Growth Rate (2017-2022)
Figure Global Humira Price (2017-2022)
Figure Global Remicade Sales Growth Rate (2017-2022)
Figure Global Remicade Price (2017-2022)
Figure Global Others Sales Growth Rate (2017-2022)
Table Global Ankylosing Spondylitis Drug Sales by Big Application (2017-2022)
Table Global Ankylosing Spondylitis Drug Sales Market Share by Big Application (2017-2022)
Figure Global Ankylosing Spondylitis Drug Sales Market Share by Big Application in 2019
Figure Global Hospitals Sales Growth Rate (2017-2022)
Figure Global Clinics Sales Growth Rate (2017-2022)
Figure Global Ankylosing Spondylitis Drug Sales and Growth Rate (2022-2027)
Figure Global Ankylosing Spondylitis Drug Revenue and Growth Rate (2022-2027)
Table Global Ankylosing Spondylitis Drug Sales Forecast by Regions (2022-2027)
Table Global Ankylosing Spondylitis Drug Market Share Forecast by Regions (2022-2027)
Figure North America Sales Ankylosing Spondylitis Drug Market Forecast (2022-2027)
Figure Europe Sales Ankylosing Spondylitis Drug Market Forecast (2022-2027)
Figure China Sales Ankylosing Spondylitis Drug Market Forecast (2022-2027)
Figure Japan Sales Ankylosing Spondylitis Drug Market Forecast (2022-2027)
Figure Southeast Asia Sales Ankylosing Spondylitis Drug Market Forecast (2022-2027)
Figure Other Regions Sales Ankylosing Spondylitis Drug Market Forecast (2022-2027)
Table Global Ankylosing Spondylitis Drug Sales Forecast by Type (2022-2027)
Table Global Ankylosing Spondylitis Drug Market Share Forecast by Type (2022-2027)
Table Global Ankylosing Spondylitis Drug Sales Forecast by Application (2022-2027)
Table Global Ankylosing Spondylitis Drug Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ankylosing Spondylitis Drug
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Ankylosing Spondylitis Drug Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Ankylosing Spondylitis Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Ankylosing Spondylitis Drug Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Ankylosing Spondylitis Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Ankylosing Spondylitis Drug Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Ankylosing Spondylitis Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Ankylosing Spondylitis Drug Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Ankylosing Spondylitis Drug Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Amgen
Wyeth
Takeda
Centocor
Schering-Plough
Mitsubishi Tanabe
Abbott
Eisai